Navigation Links
HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical

LOS ALTOS HILLS, Calif., Jan. 19, 2012 /PRNewswire/ -- HealthTech Capital announced today that it invested over $300,000 as the lead Series A2 investor in Cadence Biomedical, Inc. The move underscores the growing trend of angel investor groups joining forces to fund innovative, early-stage companies. Other investors included Alliance of Angels, Frontier Angels, Keiretsu Forum Northwest, Sand Hill Angels, and Wings. With a first close of ~$750,000 in new funds and note conversions, additional investors are expected to push the total to $1 million or more.

The funding supports the market launch of Cadence's novel device that helps people with severe disabilities walk. Worn externally, the device provides stability and movement assistance to weakened muscles without the use of powered mechanisms.

"With healthcare costs continuing their relentless march upward, creative technologies that decrease costs while improving patient care are attractive investment opportunities," said Don Ross, cofounder and managing director of HealthTech Capital. "Cadence is well positioned in the emerging HealthTech sector, and we are delighted to support such innovation with both investment dollars and hands-on mentoring."

"We are pleased to have HealthTech Capital as our lead investor," said Brian Glaister, Chief Executive Officer of Cadence. "Their domain expertise and professionalism are exceptional. They have worked with us and provide great added-value beyond their investment. With their lead, we are receiving the funding we need to bring our products to market."

"Cadence has the potential to change people's lives. When I tried the prototype, I could walk better immediately," said Donna Jang, Cadence Board Director and HealthTech Capital investor. "The experience was unlike any other in the 20 years since my stroke."

The Cadence device amplifies muscle strength, helping to propel the user forward and lift the leg and foot in preparation for the next step. Not only does it improve walking, it also has the potential to enable many who would otherwise require wheelchairs to regain strength and coordination.

About HealthTech Capital
HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where innovation improves healthcare delivery, empowers patients, and lowers costs. Founded by Anne DeGheest, Kathy La Porte, and Don Ross, HealthTech Capital has built a membership of industry leaders – successful entrepreneurs, executives, physicians, and venture capitalists – who fund and mentor new companies. For more information, please visit

About Cadence Biomedical
Cadence Biomedical is a privately held early stage medical device company whose mission is to improve mobility for people with disabilities. The company's flagship kinetic orthosis product is a revolutionary device that can provide assistance to muscles and help people with severe disabilities walk. Cadence is headquartered in Seattle, WA. For more information, please visit

SOURCE HealthTech Capital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaSecure, an Innovator in Pharmaceutical Serialization, Closes $3.9M Investment by Eric Schmidts Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund
2. HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market
3. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences
4. Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets Eighth Annual Equity Conference
5. MiMedx Group, Inc. to Present at the Noble Capital Markets 8th Annual Equity Conference
6. Avista Capital Partners Agrees to Sell BioReliance to Sigma-Aldrich Corporation
7. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
8. Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P.
9. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
10. IsZo Capital Writes to Taro Pharmaceutical Board Commenting on Management Proposals for 2011 Annual Shareholder Meeting; Reflecting on Sun Pharmas Response to Similar 2009 Proposals
11. IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders Meeting
Post Your Comments:
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):